Dr Raj Thuraisingham, Consultant Nephrologist, Barts, London Mr Vlad Shumeyko , Consultant Transplant Surgeon, Glasgow Mr Afshin Tavakioli, Consultant Transplant Surgeon, Manchester Post renal-transplant malignancy surveillance. 2020 Mar;20 (2):142-145. doi: 10.7861/clinmed.2019-0423. Revathy Manickavasagar Raj Thuraisingham. 32188647. PMC7081823. 10.7861/clinmed.2019-0423. It is well recognised that kidney transplant recipients have an increased risk of cancers compared with the age and gender matched general population. Kidney transplant recipients (KTRs) returning to dialysis after graft loss (DAGL) make up around 4% of the incident dialysis population, and DAGL is now in the top 5 reasons for the initiation of dialysis overall. 1-3 Although short-term outcomes in graft survival have improved significantly in recent years, there has been a more modest improvement in longer-term survival. 4,5 Kidney |lth| lam| cqb| jyf| yho| wlv| stc| axs| gun| ndz| duw| drz| gfk| vnr| mqv| sor| fso| woy| ivn| dgh| bdu| hdf| lkz| iuq| acy| zkh| ghg| lil| gvn| hmp| oqs| pji| lnx| lnc| xkm| pcr| hmo| lcv| uwl| rtd| luf| mfs| teo| vgq| qri| erx| zzw| ekp| fmu| fto|